CAREDX, INC. Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt
CAREDX, INC. (CDNA) reported Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt of $38.85 million for the 12-month period ending 2018-12-31, per its 10-K filed 2021-02-24.
Discontinued › Shareholders' Equity › Stock Issued During Period, Value, Conversion of Convertible Securities, Net of Adjustments
us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt · last filed 2021-02-24
- CAREDX, INC. adjustments to additional paid in capital, equity component of convertible debt for the quarter ending 2018-03-31 was $38.85M.
- CAREDX, INC. adjustments to additional paid in capital, equity component of convertible debt for fiscal 2018 was $38.85M, a 2218.14% increase from fiscal 2017.
- CAREDX, INC. adjustments to additional paid in capital, equity component of convertible debt for fiscal 2017 was $1.68M.
| Period end | Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt 3 month | Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt 12 month |
|---|---|---|
| 2018-12-31 | $38.85M 10-K · filed 2021-02-24 | |
| 2018-03-31 | $38.85M 10-Q · filed 2019-10-31 | |
| 2017-12-31 | $1.68M 10-K · filed 2020-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |